PRIMJENA METODE RIZIČNIH NOVČANIH TOKOVA NA PODUZEĆE PFIZER

master's thesis

• Title (english): APPLICATION OF CASH FLOW AT RISK METHOD ON COMPANY PFIZER
• Author: Antonio Gracin
• Mentor: Danijela Miloš Sprčić (mentor)
• Committee member: Ena Pecina (predsjednik povjerenstva)
• Committee member: Andrija Sabol (član povjerenstva)
• Granter: University of Zagreb; Faculty of Economics and Business; Zagreb
• Defense date and country: 2021-09-24, Croatia
• Scientific / art field, discipline and subdiscipline: SOCIAL SCIENCES; Economics

Abstract

Cilj ovog diplomskog rada je identificirati i kvantificirati poslovne rizike vezane uz poslovanje poduzeća Pfizer te na osnovu analize odrediti koji rizici imaju značajan utjecaj na vrijednost poduzeća te kako zaštititi poduzeće od tih rizika. Rad također uključuje analizu okruženja, industrije i poslovanja poduzeća. Za analizu rizika korištena je metoda rizičnih novčanih tokova. Na osnovi provedene analize zaključuje se da poduzeće Pfizer adekvatno upravlja poslovnim rizicima. Glavno opažanje rada je važnost veličine poduzeća u farmaceutskoj industrije. Većina analiziranih rizika imalo je umanjeni efekt jer su djelovali na samo dio proizvodnog portfelja te je samo jedan rizik imao značajan efekt upravo zato što je utjecao na sve proizvode poduzeća.

Abstract (english)

Goal of this paper is to identify and quantify business risk associated with Pfizer’s operations and based on the analysis determine which risks have significant impact on company’s value as well as how can it protect itself from those risks. Methodology used for risk analysis is cash flow at risk method (CFaR). Paper also includes environment analysis, industry analysis and business analysis for Pfizer. Based on conducted analysis, paper concludes that Pfizer has adequate risk management policies. Main observation of the paper is the importance of the company size in pharmaceutical industry. Most of the analysed risks had low effect since they affected only part of the product portfolio and only one risk had significant result because it impacted all of company’s products.

• Keywords: upravljanje rizicima; metoda rizičnih novčanih tokova; farmaceutska industrija; Pfizer
• Keywords (english): Risk management; Cash flow at risk; CFaR; Pharmaceutical industry; Pfizer
• Language: croatian
• URN:NBN: urn:nbn:hr:148:614804
• Study programme: Title: Business Economics; Study programme type: university; Study level: integrated undergraduate and graduate; Academic / professional title: magistar/magistra ekonomije (magistar/magistra ekonomije)
• Type of resource: Text
• File origin: Born digital
• Access conditions: Open access
• Created on: 2021-09-28 11:33:23